TOKYO, Jan 31, 2025 (BSS/AFP) - Takeda Pharmaceuticals has named Julie Kim as the first woman to lead the 244-year-old ...
Julie Kim has been running Takeda’s US operations since 2022 and will assume the role of CEO in June next year, subject to shareholder approval.
Analysts were unfazed by the news that Takeda will cease development of soticlestat after Phase III failures, while ...
Julie Kim, 54, has been running Takeda’s U.S. operations since 2022 and will assume the role of CEO in June next year, ...
Takeda (TAK) announced that its board of directors made the decision unanimously to appoint Julie Kim, currently president of Takeda’s U.S.